The rounds this investor is named on, who it invests beside, and where it shows up.
Named on 5 rounds in the feed, most often at Seed and in Biotech.
Asabys is an investment firm based in Barcelona, investing in healthcare and life-sciences innovation.
Venture capitalBarcelona, Spainasabys.comRounds from 2022-02-16 to 2026-10-29
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Allox A biotechnology company developing an experimental and AI-enabled platform for the systematic discovery of allosteric drug targets | Seed Verified against 4 of 36 sources | $10.5M | 2026-10-29 | [ LEAD ] |
Anaconda Biomed A Barcelona stroke-device company | Funding round Verified against 4 of |
| $56M |
| 2026-09-23 |
| [ PART ] |
iPremom Developer of MaiRa, a blood-based molecular diagnostics platform to identify first-trimester signals of pregnancy complications | Seed Verified against 4 of 6 sources | $17.4M | 2026-09-02 | [ LEAD ] |
SpliceBio SpliceBio develops next-generation gene therapies using their proprietary Protein Splicing platform, targeting diseases caused by mutations in large genes. | Series B Verified against 1 of 3 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $135M | 2025-06-11 | [ PART ] |
SpliceBio SpliceBio develops next-generation gene therapies using their proprietary Protein Splicing platform, targeting diseases caused by mutations in large genes. | Series A Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $56.9M | 2022-02-16 | [ PART ] |